News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
FDA Questions Genzyme Corporation Knee Pain Treatment Study
December 5, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON, Dec 5 (Reuters) - A study of Genzyme Corp's latest version of its injectable knee pain treatment may not be strong enough to support the therapy, U.S. regulatory reviewers said in an analysis released on Friday.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase II
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Pain
Lexicon Backs Phase III Go Decision for Non-Opioid Pain Med With Post-Hoc Analysis
September 18, 2025
·
2 min read
·
Tristan Manalac
Cardiovascular disease
Deep Dive: Oral Obesity Drugs on the Cusp
September 18, 2025
·
3 min read
·
Heather McKenzie
IN PARTNERSHIP WITH Pii, A JABIL COMPANY
Webinar: Bridging Formulation & Device | Integrated Supply Chain Strategies for US Pharma Manufacturing
September 17, 2025
·
1 min read
·
BioSpace Insights
Podcast
China Crackdown, UK Exit, Novo Layoffs, Adcomm Flip Flop, More
September 17, 2025
·
2 min read
·
Heather McKenzie
